Index Catalog // STAX

Remover filtros

Filtragem por: Contribuinte GlaxoSmithKline O Criador Hooper-Greenhill, Edward

Early application of mechanistic PKPD modelling to guide the preclinical development of a therapeutic mAb targeting complement receptor 2 (CR2/CD21) as a novel target for the treatment of autoimmune disease

O Criador:

Hooper-Greenhill, Edward

Encontro:

2021

Funder:

GlaxoSmithKline

Department, School or Faculty:

Strathclyde Institute of Pharmacy and Biomedical Sciences